The estimated cumulative risks of breast cancer by age 70 in two meta-analyses were 55% to 65% for carriers of BRCA1 pathogenic variants and 45% to 47% for carriers of BRCA2 pathogenic variants [3]. The gene discussed is BRCA2; the disease is breast cancer.